Literature DB >> 35064827

First do no harm: use off-label antipsychotic medication in children and adolescents with great caution.

Pieter J Hoekstra1, Andrea Dietrich2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35064827     DOI： 10.1007/s00787-022-01950-7

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN： 1018-8827            Impact factor:   4.785


× No keyword cloud information.
  10 in total

1.  Movement disorders and use of risperidone and methylphenidate: a review of case reports and an analysis of the WHO database in pharmacovigilance.

Authors:  Dominik Stämpfli; Stefan Weiler; Andrea M Burden
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-07-03       Impact factor: 4.785

2.  Severely Aggressive Children Receiving Stimulant Medication Versus Stimulant and Risperidone: 12-Month Follow-Up of the TOSCA Trial.

Authors:  Kenneth D Gadow; Nicole V Brown; L Eugene Arnold; Kristin A Buchan-Page; Oscar G Bukstein; Eric Butter; Cristan A Farmer; Robert L Findling; David J Kolko; Brooke S G Molina; Robert R Rice; Jayne Schneider; Michael G Aman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2016-04-13       Impact factor: 8.829

3.  Antipsychotic Treatment Duration in Children and Adolescents: A Register-Based Nationwide Study.

Authors:  Eveliina Varimo; Eeva T Aronen; Hannu Mogk; Hanna Rättö; Leena K Saastamoinen
Journal:  J Child Adolesc Psychopharmacol       Date:  2021-03-18       Impact factor: 2.576

4.  Outpatient antipsychotic drug use in children and adolescents in Germany between 2004 and 2011.

Authors:  Carsten Schröder; Michael Dörks; Bianca Kollhorst; Tilo Blenk; Ralf W Dittmann; Edeltraut Garbe; Oliver Riedel
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-09-13       Impact factor: 4.785

5.  Risk of seizures associated with antipsychotic treatment in pediatrics with psychiatric disorders: a nested case-control study in Korea.

Authors:  Soo Min Jeon; Susan Park; Dohoon Kim; Jin-Won Kwon
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-04-07       Impact factor: 4.785

6.  Antipsychotics in Dutch Youth: Prevalence, Dosages, and Duration of Use from 2005 to 2015.

Authors:  Sanne M Kloosterboer; Catharina C M Schuiling-Veninga; Jens H J Bos; Luuk J Kalverdijk; Birgit C P Koch; Gwen C Dieleman; Manon H J Hillegers; Bram Dierckx
Journal:  J Child Adolesc Psychopharmacol       Date:  2018-03-13       Impact factor: 2.576

7.  Home-based parent training for school-aged children with attention-deficit/hyperactivity disorder and behavior problems with remaining impairing disruptive behaviors after routine treatment: a randomized controlled trial.

Authors:  Ellen Nobel; Pieter J Hoekstra; J Agnes Brunnekreef; Dieneke E H Messink-de Vries; Barbara Fischer; Paul M G Emmelkamp; Barbara J van den Hoofdakker
Journal:  Eur Child Adolesc Psychiatry       Date:  2019-07-22       Impact factor: 4.785

8.  Prescribing antipsychotics in child and adolescent psychiatry: guideline adherence.

Authors:  Mariken Dinnissen; Andrea Dietrich; Judith H van der Molen; Anne M Verhallen; Ynske Buiteveld; Suzanne Jongejan; Pieter W Troost; Jan K Buitelaar; Pieter J Hoekstra; Barbara J van den Hoofdakker
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-02-12       Impact factor: 4.785

9.  Stepped Treatment for Attention-Deficit/Hyperactivity Disorder and Aggressive Behavior: A Randomized, Controlled Trial of Adjunctive Risperidone, Divalproex Sodium, or Placebo After Stimulant Medication Optimization.

Authors:  Joseph C Blader; Steven R Pliszka; Vivian Kafantaris; Carmel A Foley; Gabrielle A Carlson; Judith A Crowell; Brigitte Y Bailey; Colin Sauder; W Burleson Daviss; Christa Sinha; Thomas L Matthews; David M Margulies
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2020-01-30       Impact factor: 8.829

10.  Trends Over Time in Antipsychotic Initiation at a Large Children's Health Care System.

Authors:  Laura J Chavez; Kelly J Kelleher; Arne Beck; Gregory N Clarke; Robert B Penfold
Journal:  J Child Adolesc Psychopharmacol       Date:  2021-06       Impact factor: 3.031
  10 in total
  1 in total

1.  COVID-19 and Youth Psychopathological Distress in Umbria, Central Italy: A 2-Year Observational Study in a Real-World Setting.

Authors:  Giulia Menculini; Giorgio Pomili; Francesca Brufani; Agnese Minuti; Niccolò Mancini; Martina D'Angelo; Sonia Biscontini; Enrico Mancini; Andrea Savini; Laura Orsolini; Umberto Volpe; Alfonso Tortorella; Luca Steardo
Journal:  Front Psychiatry       Date:  2022-05-19       Impact factor: 5.435
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.